Anebulo Pharmaceuticals
ANEB
ANEB
15 hedge funds and large institutions have $21M invested in Anebulo Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
15
Holders Change
+1
Holders Change %
+7.14%
% of All Funds
0.22%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
4
Increased
2
Reduced
5
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$72.5K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$65.4K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.35K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$413 |
| 5 |
JPMorgan Chase & Co
New York
|
+$26 |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$1.15M |
| 2 |
LCM
Landscape Capital Management
Englewood,
New Jersey
|
-$36.3K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$11.4K |
| 4 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
-$2.95K |
| 5 |
LA
LVW Advisors
Pittsford,
New York
|
-$2.87K |
